Pura Vida Investments
New York, New York, United StatesFounded 2012
Pura Vida Investments is a New York-based, healthcare-focused investment firm employing a fundamentally-driven, market-neutral approach. It invests across medical technology, diagnostics, genomics, biopharmaceuticals, and health-tech, spanning both public and private markets.
54% of their portfolio is in Healthcare. Average disclosed round size is $165.6M (across 23 rounds with reported amounts).
Portfolio
20
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
AG
Aditya Gupta
Principal
GO
Gerrel Olivier
Senior Analyst
TH
Tae-Il Ha
Senior Analyst
BB
Beau Bassett
Investment Manager
MN
Matthew Newton
Head of Equities
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
26 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 AtaiBeckley | Series C | — | Jan 2025 |
 Nalu | Series E | $65M | Mar 2024 |
 Freenome | Growth | $254M | Feb 2024 |
| Nalu | Series E | $85M | Jan 2024 |
 Beta Bionics | Series C | $57M | Feb 2022 |
 Cleerly | Series C | $106M | Jan 2022 |
| Freenome | Series D | $300M | Dec 2021 |
 NanoMosaic | Series A | $40.8M | Dec 2021 |
 Exo Labs | Series C | $220M | Jul 2021 |
 Caris Life Sciences | Growth | $830M | May 2021 |
 Lumicks | Series D | $93M | Apr 2021 |
| LLumicks B.V. | Series D | $93M | Apr 2021 |
| Lumicks | Series D | $93M | Jan 2021 |
 V-Wave | Series C | $98M | Sep 2020 |
 Willow | Series C | $55M | Sep 2020 |
| AAcutus | Series D | $295M | Jan 2019 |
 Acutus Medical | Series D | — | Jan 2019 |
 MedAvail | Bridge | $84M | Jan 2018 |
| V-Wave | Series B | $28M | Jan 2016 |
 Nalu Medical | Series E | $85M | Jan 2015 |
| AtaiBeckley | Growth | $43M | — |
 Exo | Series C | — | — |
 Monogram | Unknown | $375M | — |
 Imperative Care | Series D | $260M | — |
 Exo Imaging | Series C | $220M | — |
Page 1 of 2
Top Co-Investors
T. Rowe Price7 shared
RA Capital Management6 shared
Sands Capital6 shared
Endeavour Vision6 shared
Gilde Healthcare6 shared
Farallon Capital Management5 shared
Perceptive Advisors5 shared
Deerfield5 shared
Aperture Venture Partners4 shared
Catalio Capital Management3 shared
Eventide Asset Management3 shared
ArrowMark Partners3 shared
Bain Capital Life Sciences3 shared
Rock Springs Capital3 shared
Avidity Partners3 shared
OrbiMed3 shared
The Cigna Group Ventures3 shared
Longitude Capital3 shared
Decheng Capital3 shared
B Capital3 shared
Last updated: 20 October 2026